Drug: SANDOSTATIN LAR DEPOT Injury: Malignant neoplasm progression Quarter: 2016Q3
Total Records: 107 Number of Pages: 6
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
1132703519 | SANDOSTATIN LAR DEPOT | Malignant neoplasm progression | SANDOZ | 70.33 YR | M | 0 | 20160719 | COUNTRY NOT SPECIFIED |
1150707810 | SANDOSTATIN LAR DEPOT | Malignant neoplasm progression | NOVARTIS | 59.06 YR | F | 0 | 20160830 | AU |
1158405411 | SANDOSTATIN LAR DEPOT | Malignant neoplasm progression | VALIDUS | 0.00 | 0 | 20160722 | CA | |
1163042415 | SANDOSTATIN LAR DEPOT | Malignant neoplasm progression | SANDOZ | 50.57 YR | F | 0 | 20160908 | CA |
1169545312 | SANDOSTATIN LAR DEPOT | Malignant neoplasm progression | SANDOZ | 68.19 YR | M | 0 | 20160915 | CA |
1186418410 | SANDOSTATIN LAR DEPOT | Malignant neoplasm progression | NOVARTIS | 42.35 YR | F | 0 | 20160906 | CA |
1225473820 | SANDOSTATIN LAR DEPOT | Malignant neoplasm progression | SANDOZ | 62.42 YR | M | 0 | 20160930 | AU |
Total Records: 107 Number of Pages: 6